Location History:
- Narita, JP (1992)
- Chiba, JP (2009)
Company Filing History:
3 out of 90 
1 out of 375 Years Active: 1992-2009
Title: Tetsuo Kaneko: Innovator in Liquid Drug Preparations and Ointments
Introduction
Tetsuo Kaneko is an accomplished inventor based in Narita, Japan, with a notable portfolio of four patents. His innovative contributions primarily focus on liquid drug preparations and corticosteroid-containing ointments, enhancing the efficacy and usability of pharmaceutical products.
Latest Patents
Kaneko's latest patents include advancements in liquid drug preparations, specifically formulations characterized by containing fudostein and an acid, combined with sweeteners such as sugar alcohol or trehalose. These formulations are designed to remain free from color change or sedimentation over prolonged storage, making them easier for patients to consume. Another significant patent involves corticosteroid-containing ointments, comprising a careful blend of deprodone propionate and a base composed of white petroleum and a liquid hydrocarbon. This ointment can also contain a polyhydric alcohol, providing enhanced properties and usability for topical applications.
Career Highlights
Throughout his career, Tetsuo Kaneko has made significant strides in the pharmaceutical industry, working with reputable companies such as Ss Pharmaceutical Co., Ltd. and Hisamitsu Pharmaceutical Company, Inc. His work has focused on developing formulations that improve patient compliance and treatment efficacy.
Collaborations
Kaneko has had the opportunity to work alongside prominent professionals in the field, including coworkers Katsumi Imamori and Takashi Narui. These collaborations have facilitated the exchange of ideas and expertise, further driving innovation in drug formulation.
Conclusion
Tetsuo Kaneko stands out as a key figure in the realm of pharmaceuticals, with a strong emphasis on developing effective and user-friendly drug preparations. His contributions through various patents not only highlight his innovative spirit but also mark significant advancements in the pharmaceutical industry, ultimately benefiting patients and healthcare providers alike.